Following decades of strategic advocacy, research investment, and biopharmaceutical development, the U.S. Duchenne community recently arrived in the post-approval space and is poised to receive additional novel therapies from a robust innovation pipeline. Parent Project Muscular Dystrophy (PPMD) is deeply engaged on behalf of families nationwide as industry sponsors work with the Food & Dr…